Home

About

Contact Us

Home

About

Contact Us

Our Story

About Us

At ASK BioConsult, we combine deep clinical insight with strategic vision to help health-focused organizations solve complex problems.

0

+

Healthcare Projects Delivered

0

+

Biotech & MedTech Clients

0

x

Average Client ROI

0

+

Medicines Brought To Market

Who We Are

Meet Dr. Kalsi

Meet Dr. Kalsi

Meet Dr. Kalsi

Meet Dr. Kalsi

Dr Kalsi brings more than 20 years of experience in global clinical development, medical affairs, investment strategy and regulatory affairs to Asklepion Pharmaceuticals, LLC.

Dr Kalsi brings more than 20 years of experience in global clinical development, medical affairs, investment strategy and regulatory affairs to Asklepion Pharmaceuticals, LLC.

Contact Us

Feature Image
Feature Image

Dr. Kalsi served as the SVP/CMO of Tissue Gene, where he headed medical, clinical and regulatory development functions in cell and gene therapeutics and helped IPO its lead asset in Knee OA on the KOSDAQ. Prior to his time with Tissue Gene, Dr. Kalsi served as Corporate Vice President for Clinical Development & Medical Affairs at Emergent BioSolutions Inc. At MDS Pharma, he was the head of Medical Affairs and Regulatory Affairs. Dr. Kalsi held executive leadership positions with ICON plc in clinical development and medical affairs.

Dr. Kalsi served as the SVP/CMO of Tissue Gene, where he headed medical, clinical and regulatory development functions in cell and gene therapeutics and helped IPO its lead asset in Knee OA on the KOSDAQ. Prior to his time with Tissue Gene, Dr. Kalsi served as Corporate Vice President for Clinical Development & Medical Affairs at Emergent BioSolutions Inc. At MDS Pharma, he was the head of Medical Affairs and Regulatory Affairs. Dr. Kalsi held executive leadership positions with ICON plc in clinical development and medical affairs.

He began his pharmaceutical career at Lundbeck A/S in Copenhagen, Denmark. Dr. Kalsi received his medical degrees in surgery and medicine from Glancy Medical College (GMC), followed by postgraduate training courses in public health medicine at St George’s Hospital in London and Pharmaceutical Medicine postgraduate training at Cardiff University, UK. He is a member of the British Association of Pharmaceutical Physicians and Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians.

He began his pharmaceutical career at Lundbeck A/S in Copenhagen, Denmark. Dr. Kalsi received his medical degrees in surgery and medicine from Glancy Medical College (GMC), followed by postgraduate training courses in public health medicine at St George’s Hospital in London and Pharmaceutical Medicine postgraduate training at Cardiff University, UK. He is a member of the British Association of Pharmaceutical Physicians and Faculty of Pharmaceutical Medicine, Royal Colleges of Physicians.

Our Approach

Areas of Focus

Areas of Focus

Areas of Focus

We work at the intersection of health, biotech, and medtech to support medical breakthroughs. Our work spans public health initiatives, cutting-edge biologics, and medical technologies.

We work at the intersection of health, biotech, and medtech to support medical breakthroughs. Our work spans public health initiatives, cutting-edge biologics, and medical technologies.

Learn More

Health

Explore

We help health-focused organizations connect with patients, partners, and communities through clear communication, trusted design, and technology that supports well-being.

Biotech

Explore

Biotech innovation demands precision, clarity, and credibility. We partner with research-driven teams and emerging life sciences companies to translate complex science.

MedTech

Explore

From wearables to AI-powered diagnostics, MedTech innovations are reshaping how care is delivered and decisions are made. We help organizations navigate regulatory complexity.

What We Do

To accelerate the development of transformative health solutions by bridging scientific discovery, clinical insight, and strategic execution.

To accelerate the development of transformative health solutions by bridging scientific discovery, clinical insight, and strategic execution.

What We Do

To accelerate the development of transformative health solutions by bridging scientific discovery, clinical insight, and strategic execution.

What We Do

To accelerate the development of transformative health solutions by bridging scientific discovery, clinical insight, and strategic execution.